T04.01.7 MAINTENANCE OF CLINICAL REMISSION WITH SB5 BIOSIMILAR AFTER SWITCH FROM ADALIMUMAB ORIGINATOR: REAL-LIFE EXPERIENCE OF A TERTIARY REFERRAL CENTER
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI